Bay­er, Astel­las gear up for next CEOs; Ex-AM­AG chief Scott My­ers resur­faces at Virid­i­an

→ You know how we told you last week that we’d keep our eyes peeled for where ex-Roche Phar­ma­ceu­ti­cals CEO Bill An­der­son turns up next? Well, he gave us an an­swer in a big way.

An­der­son will be the CEO at Bay­er start­ing April 1, the Ger­man phar­ma said Wednes­day. Un­like Roche, Mer­ck, J&J and the CEO tran­si­tion that fol­lows, Bay­er chose not to go in-house for Wern­er Bau­mann’s re­place­ment. In­vestors have been grum­bling about the com­pa­ny’s stock per­for­mance, so much so that ac­tivist in­vestor Jeff Ubben ral­lied the troops to find some­one out­side the com­pa­ny to take con­trol. In the end, the in­vestors won.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER